<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Cambridge Institute for Medical Research</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D0755B3B-8632-4E69-A77F-F8D43979361B"><gtr:id>D0755B3B-8632-4E69-A77F-F8D43979361B</gtr:id><gtr:firstName>Paul J</gtr:firstName><gtr:surname>Lehner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600823"><gtr:id>C9ED318A-DE4F-4694-AC5B-DE9D4AF4C140</gtr:id><gtr:title>The role of MARCH1 in the ubiquitination and regulation of surface immunoreceptors</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600823</gtr:grantReference><gtr:abstractText>We are trying to find ways in which cells in our body hide from our immune system, which may allow them to develop into cancers. 

To prevent a cell becoming cancerous and allow normal cell growth, all cells have receptors at their surface. These receptors need to be tightly controlled. The addition of small tags called ubiquitin onto these receptors causes their removal. 

Herpesviruses have devised ingenious ways of adding ubiquitin tags to important cell surface receptors, leading to the receptors? removal. Viruses are cunning and stole this idea from our own cells. This led to the discovery of a new family of genes ?called the MARCH family. We found that MARCHs play an important role in regulating receptors of our immune system. 

Our preliminary evidence suggests that MARCH proteins control immune cell activity to ensure that cells are neither over- nor under-active. We will use modern molecular techniques to find out how MARCH proteins control cell surface receptors.

This will be important for learning about (i) how immune cells work (ii) whether MARCH proteins will be good drug targets to prevent immune-mediated disease and (iii) whether they allow cells to escape the immune system and develop into cancers.</gtr:abstractText><gtr:technicalSummary>The regulation of cell surface receptors is essential for the maintenance of cell homeostasis. At the plasma membrane, ubiquitination is an important post-translational mechanism for controlling expression of many critical proteins including immunoreceptors, and targets receptors for degradation by proteasomal or lysosomal pathways. The critical ubiquitin enzyme is the E3 ligase which binds the substrate and therefore confers specificity to the reaction.

Our studies on viral immunoevasion of MHC class I identified the K3 family of viral membrane-associated ubiquitin E3 ligases which downregulate surface MHC class I and other critical immunoreceptors. These viral E3 ligases have been appropriated from the host genome and ten mammalian orthologues of the K3 viral family identified - the MARCH genes. Although their physiological function remains unclear, MARCH proteins are ubiquitin E3 ligases and downregulate cell surface receptors. A MARCH7 deficient mouse shows uncontrolled T cell proliferation and develops autoimmunity. 

MARCH1 is an ubiquitin E3 ligase whose expression is tightly restricted to B cells. MARCH1 deficient mice are predicted to be unable to downregulate some B cell receptors and express increased surface levels of MARCH1 substrates. The aims of this project are (i) the generation of genetically modified MARCH1 mice, to allow (ii) the identification of MARCH1 substrate(s) and (iii) characterisation of the phenotype and physiological role of MARCH1 in the immune system. These targets will be identified initially using a candidate gene approach to compare expression of B cell receptors from MARCH1 deficient and wildtype cells by flow cytometry. For a more objective analysis we will collaborate with Dr Kathryn Lilley in the Cambridge Centre for Proteomics and profile B cell plasma membrane proteins to compare receptor expression in MARCH1 deficient and wildtype B cells using ITRAQ labelling and mass spectrometry. 

Following identification of MARCH1 targets, the impact of impaired receptor regulation on B cell function will be determined in collaboration with Dr Ken Smith, a B cell immunologist in CIMR. The biochemical activity and mechanism of action of MARCH1 will be characterised and the impact of MARCH1 mutants tested in vivo and in vitro.

The work proposed in this project will identify the targets and physiological role of MARCH1, a ubiquitin E3 ligase we believe plays an important role in B cell regulation. It will provide insight into the role of ubiquitin in regulating B cell receptors and the importance of the MARCH family in immune cell function.</gtr:technicalSummary><gtr:fund><gtr:end>2010-03-02</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-03-03</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>292701</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>visit from sixth formers</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>23641769-34BE-48EC-A8F4-5186C232FC6A</gtr:id><gtr:impact>Students visited the laboratory and took part in some practical work.

School requested further visits due to positive feedback</gtr:impact><gtr:outcomeId>ZdsoxzLu9o1</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit from pharmaceutical company</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9CD2DA02-2BAE-4623-83E4-C6A40BF0E1B5</gtr:id><gtr:impact>10 representatives from a pharmaceutical company attended a brain-storming session to discuss possible future collaborations

Company have suggested we discuss certain aspects of work further.</gtr:impact><gtr:outcomeId>JBXQK7KhYe7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>205398</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust project grant (TRC8, a novel ERAD ubiquitin E3 ligase in the regulation of MHC class I and other substrates)</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>46926490-D02D-417E-A5AB-74E23D7F0144</gtr:id><gtr:outcomeId>DSHsE4AeHND0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1655728</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Senior Clinical Fellowship (The control of MHC class I by viral and cellular E3 ligases)</gtr:description><gtr:end>2013-07-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>4842C058-14A5-49BF-9C3C-66D2C14F6FCB</gtr:id><gtr:outcomeId>huCTyhYB47J0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>177951</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project grant (HSP70 as immune potentiator for vaccines in infection and conditions of immune imbalance.)</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>B1B8D3E8-255B-4995-B824-DDB7E2B302A8</gtr:id><gtr:outcomeId>rAek5zYDE1t0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Equipment grant</gtr:description><gtr:end>2012-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>A02995C0-9528-4070-BE63-9258CE4AEECC</gtr:id><gtr:outcomeId>mdChMssSXdX0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have generated a MARCH-deficient mouse and are characterizing its phenotype</gtr:description><gtr:id>2E80B842-12B7-42FE-9FA1-92F6D40CB022</gtr:id><gtr:impact>Too early to say</gtr:impact><gtr:outcomeId>F4C3C6BF6A2</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>MARCH-deficient mouse</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>05F38BC4-FFB6-4110-9BB4-3E61FFF34040</gtr:id><gtr:title>Efficient internalization of MHC I requires lysine-11 and lysine-63 mixed linkage polyubiquitin chains.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeed9b26eaeb5e8deb421da7d5b49425"><gtr:id>aeed9b26eaeb5e8deb421da7d5b49425</gtr:id><gtr:otherNames>Boname JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>rwD6tSp7hWZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>700F35A1-44EC-440F-B9EA-A24604B1CD3A</gtr:id><gtr:title>The trafficking and regulation of membrane receptors by the RING-CH ubiquitin E3 ligases.</gtr:title><gtr:parentPublicationTitle>Experimental cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/193c3f67cc0e02baa5ad5779f7aa9c10"><gtr:id>193c3f67cc0e02baa5ad5779f7aa9c10</gtr:id><gtr:otherNames>Nathan JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-4827</gtr:issn><gtr:outcomeId>HRSPAQi7sCU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C7C0C3DE-1204-49E5-957A-D694D4E860BC</gtr:id><gtr:title>Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins block distinct steps in transendothelial migration of effector memory CD4+ T cells by targeting different endothelial proteins.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e32ba6f132d6e5cc028928b68c3fdf99"><gtr:id>e32ba6f132d6e5cc028928b68c3fdf99</gtr:id><gtr:otherNames>Manes TD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>SisPh9UGtES</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>97B61D9B-3ED3-4790-8548-B66C1F6B7629</gtr:id><gtr:title>MARCH-IX mediates ubiquitination and downregulation of ICAM-1.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d08be130b908d7e59f62e631bc5ec893"><gtr:id>d08be130b908d7e59f62e631bc5ec893</gtr:id><gtr:otherNames>Hoer S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>etWqAKemQkq</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC10C77E-995A-4E7C-8919-40227E75962E</gtr:id><gtr:title>A 58-year-old woman with abdominal symptoms and elevated C-reactive protein.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93b31ed653407a8c19a91c24d47860ce"><gtr:id>93b31ed653407a8c19a91c24d47860ce</gtr:id><gtr:otherNames>Daly ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>pjpXAoyozir</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D074BB0-4759-4396-BB47-6AE77A6F0E63</gtr:id><gtr:title>The ubiquitin E3 ligase MARCH7 is differentially regulated by the deubiquitylating enzymes USP7 and USP9X.</gtr:title><gtr:parentPublicationTitle>Traffic (Copenhagen, Denmark)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/193c3f67cc0e02baa5ad5779f7aa9c10"><gtr:id>193c3f67cc0e02baa5ad5779f7aa9c10</gtr:id><gtr:otherNames>Nathan JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1398-9219</gtr:issn><gtr:outcomeId>dQuwcWysj8k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>99163E7D-E865-4E0E-8298-DE01A6BE38E4</gtr:id><gtr:title>Viral avoidance and exploitation of the ubiquitin system.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d831d764597269adc1d1578ce82b3c55"><gtr:id>d831d764597269adc1d1578ce82b3c55</gtr:id><gtr:otherNames>Randow F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>doG3x38SouN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F63E2EC-D5D5-4531-9399-259C146182DD</gtr:id><gtr:title>What has the study of the K3 and K5 viral ubiquitin E3 ligases taught us about ubiquitin-mediated receptor regulation?</gtr:title><gtr:parentPublicationTitle>Viruses</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeed9b26eaeb5e8deb421da7d5b49425"><gtr:id>aeed9b26eaeb5e8deb421da7d5b49425</gtr:id><gtr:otherNames>Boname JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1999-4915</gtr:issn><gtr:outcomeId>pm_16047_27_22049306</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42F74441-89D8-4BE0-A261-E76F77703A59</gtr:id><gtr:title>Structure and function: heat shock proteins and adaptive immunity.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/903c094a6c5f308416c2cb40d69b5716"><gtr:id>903c094a6c5f308416c2cb40d69b5716</gtr:id><gtr:otherNames>Javid B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>585d4eb10f58c4.64279886</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9EA59D6-F743-4D95-9A4C-38038F27EED3</gtr:id><gtr:title>Endosomal transport via ubiquitination.</gtr:title><gtr:parentPublicationTitle>Trends in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a011a2d7506e781ad1f1cbcf9f548f4b"><gtr:id>a011a2d7506e781ad1f1cbcf9f548f4b</gtr:id><gtr:otherNames>Piper RC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0962-8924</gtr:issn><gtr:outcomeId>pm_16047_27_21955996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA06BF6F-2D33-4588-B0DD-D208C24B5CF9</gtr:id><gtr:title>Natural killer cell evasion by an E3 ubiquitin ligase from Kaposi's sarcoma-associated herpesvirus.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20d02bc2c32cfe6f4c97355b57afcfe4"><gtr:id>20d02bc2c32cfe6f4c97355b57afcfe4</gtr:id><gtr:otherNames>Thomas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>Kf4HEj8XR1k</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>653320E0-3E17-40EC-B588-E756C15D2825</gtr:id><gtr:title>Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/20d02bc2c32cfe6f4c97355b57afcfe4"><gtr:id>20d02bc2c32cfe6f4c97355b57afcfe4</gtr:id><gtr:otherNames>Thomas M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>b3oJ7bnFwxy</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E20739A-EA12-42B4-A1FC-B8BBE0ECEA6B</gtr:id><gtr:title>The dominantly expressed class I molecule of the chicken MHC is explained by coevolution with the polymorphic peptide transporter (TAP) genes.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b220d5581aee43d01f4d8053176db86"><gtr:id>1b220d5581aee43d01f4d8053176db86</gtr:id><gtr:otherNames>Walker BA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_16047_27_21536896</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAD202CB-C857-4DB2-89A1-FF0B6F4EDC4B</gtr:id><gtr:title>The varicellovirus UL49.5 protein blocks the transporter associated with antigen processing (TAP) by inhibiting essential conformational transitions in the 6+6 transmembrane TAP core complex.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/26d1f0f0df0a5f6c0644cb3bec7a5e03"><gtr:id>26d1f0f0df0a5f6c0644cb3bec7a5e03</gtr:id><gtr:otherNames>Verweij MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>585d4e7396e744.25575679</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B402FD41-8402-4846-876A-FB1CD282945D</gtr:id><gtr:title>Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f706d89e3483fb96ead3a5b0cefe32ae"><gtr:id>f706d89e3483fb96ead3a5b0cefe32ae</gtr:id><gtr:otherNames>Duncan LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>SSCPZ74PdLm</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C08C24EF-6073-4FC8-BE28-6226C2EFAD31</gtr:id><gtr:title>Comparative analysis of techniques to purify plasma membrane proteins.</gtr:title><gtr:parentPublicationTitle>Journal of biomolecular techniques : JBT</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b895d6f1022449850bff9b154540eb7"><gtr:id>6b895d6f1022449850bff9b154540eb7</gtr:id><gtr:otherNames>Weekes MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1524-0215</gtr:issn><gtr:outcomeId>Mt7yy8Lnoon</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEF327CC-2586-4189-A6BF-5B6F7BA95132</gtr:id><gtr:title>Identification of a lysosomal pathway regulating degradation of the bone morphogenetic protein receptor type II.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1061ffb7154c7807c902f2cdd6308025"><gtr:id>1061ffb7154c7807c902f2cdd6308025</gtr:id><gtr:otherNames>Durrington HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>oN7LLgisfMM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D57D5B5A-01E2-432A-BFBE-82CD528E1DF6</gtr:id><gtr:title>Analysis of the human E2 ubiquitin conjugating enzyme protein interaction network.</gtr:title><gtr:parentPublicationTitle>Genome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/94e17d68f41abc56eb35c8340d5ef7bb"><gtr:id>94e17d68f41abc56eb35c8340d5ef7bb</gtr:id><gtr:otherNames>Markson G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1088-9051</gtr:issn><gtr:outcomeId>gHqb3o7RrjK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EA803E3-3020-4F93-AFAB-2962A569811F</gtr:id><gtr:title>The TRC8 E3 ligase ubiquitinates MHC class I molecules before dislocation from the ER.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/65cbd9d842ba99e94f69ec7e2078218c"><gtr:id>65cbd9d842ba99e94f69ec7e2078218c</gtr:id><gtr:otherNames>Stagg HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn><gtr:outcomeId>WdRpkmHztKJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA6183E7-FD68-4874-BD24-7C86197EF4DB</gtr:id><gtr:title>RNA-binding E3 ubiquitin ligases: novel players in nucleic acid regulation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fbcad82585b37e480939c9b187de13c5"><gtr:id>fbcad82585b37e480939c9b187de13c5</gtr:id><gtr:otherNames>Cano F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_16047_27_21118137</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5074797-D8F5-4832-B2CE-53B7CD57231D</gtr:id><gtr:title>HRD1 and UBE2J1 target misfolded MHC class I heavy chains for endoplasmic reticulum-associated degradation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bea27a64added2d5a22ca52181f8329c"><gtr:id>bea27a64added2d5a22ca52181f8329c</gtr:id><gtr:otherNames>Burr ML</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_16047_27_21245296</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43ADD84E-E524-48A4-AF9A-0B80085F09EC</gtr:id><gtr:title>ESCRT proteins and the regulation of endocytic delivery to lysosomes.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fc6f9406053cf1ae64fabe43b59af90"><gtr:id>1fc6f9406053cf1ae64fabe43b59af90</gtr:id><gtr:otherNames>Luzio JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>V7pCZ4ucocG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA5D3208-8AAC-476D-9519-56606D3F1102</gtr:id><gtr:title>Dendritic cell stimulation by mycobacterial Hsp70 is mediated through CCR5.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/592ee7649769732bf204fc9e96a82554"><gtr:id>592ee7649769732bf204fc9e96a82554</gtr:id><gtr:otherNames>Floto RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>cxkGQpQNqHs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68E95267-0B1A-4471-9882-04C18B55EF92</gtr:id><gtr:title>Stable isotope labeling by amino acids in cell culture and differential plasma membrane proteome quantitation identify new substrates for the MARCH9 transmembrane E3 ligase.</gtr:title><gtr:parentPublicationTitle>Molecular &amp; cellular proteomics : MCP</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d09e0817850a42fff01e266a60ae54df"><gtr:id>d09e0817850a42fff01e266a60ae54df</gtr:id><gtr:otherNames>H?r S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1535-9476</gtr:issn><gtr:outcomeId>LFPGPY2DNRW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F7D3B81-E8CB-4EC2-B337-7A7BC3F87606</gtr:id><gtr:title>Ubiquitination of lysine-331 by Kaposi's sarcoma-associated herpesvirus protein K5 targets HFE for lysosomal degradation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/180a3baa4fd8918b9d49365fa2a8e310"><gtr:id>180a3baa4fd8918b9d49365fa2a8e310</gtr:id><gtr:otherNames>Rhodes DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>nE2Mg1R76zj</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F67ADF6B-62E3-4E88-81D4-7E6A37DEDDD2</gtr:id><gtr:title>Stabilization of an E3 ligase-E2-ubiquitin complex increases cell surface MHC class I expression.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f706d89e3483fb96ead3a5b0cefe32ae"><gtr:id>f706d89e3483fb96ead3a5b0cefe32ae</gtr:id><gtr:otherNames>Duncan LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>jobFHz6FZqt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ECBC906E-7E7B-494D-B4DC-E8A93236F1A6</gtr:id><gtr:title>First report of Salmonella enterica serotype paratyphi A azithromycin resistance leading to treatment failure.</gtr:title><gtr:parentPublicationTitle>Journal of clinical microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/526a8e6f0de08cf215c0d49ff38df22f"><gtr:id>526a8e6f0de08cf215c0d49ff38df22f</gtr:id><gtr:otherNames>Molloy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0095-1137</gtr:issn><gtr:outcomeId>AJfVJKWmeyC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AD036524-DBBA-4AF9-BB4D-D43B76D3EB9B</gtr:id><gtr:title>HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/959108cc02e2639df0939fb7c23cd781"><gtr:id>959108cc02e2639df0939fb7c23cd781</gtr:id><gtr:otherNames>Lubben NB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn><gtr:outcomeId>T6R3sbCJan9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4FB18742-F711-4FA0-B644-C62F4F470490</gtr:id><gtr:title>Jenner's irony: cowpox taps into T cell evasion.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8a2735a3ab0c4d75ed431e7759769ce"><gtr:id>d8a2735a3ab0c4d75ed431e7759769ce</gtr:id><gtr:otherNames>Wilkinson GW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn><gtr:outcomeId>KjqH9Y4rfYR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A124A7D3-AB3A-4F70-9A2C-E01DB59C84C4</gtr:id><gtr:title>Degradation of endocytosed epidermal growth factor and virally ubiquitinated major histocompatibility complex class I is independent of mammalian ESCRTII.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93c4ce9d061ef1b820a246dbe1a5572f"><gtr:id>93c4ce9d061ef1b820a246dbe1a5572f</gtr:id><gtr:otherNames>Bowers K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>AMUdaMT3fK9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B6088773-2657-4108-9632-17DCE4F097DF</gtr:id><gtr:title>Orthotopic liver transplantation for subacute hepatic failure following partial treatment of isoniazid-resistant tuberculosis.</gtr:title><gtr:parentPublicationTitle>Transplant infectious disease : an official journal of the Transplantation Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e4dc17e37741f920cf6ba93746ff205a"><gtr:id>e4dc17e37741f920cf6ba93746ff205a</gtr:id><gtr:otherNames>Nash KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1398-2273</gtr:issn><gtr:outcomeId>ZRN4VomqCyD</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600823</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>